Logo image of QSI

QUANTUM-SI INC (QSI) Stock Fundamental Analysis

USA - NASDAQ:QSI - US74765K1051 - Common Stock

1.655 USD
+0.08 (+5.08%)
Last: 11/10/2025, 2:59:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to QSI. QSI was compared to 58 industry peers in the Life Sciences Tools & Services industry. While QSI has a great health rating, there are worries on its profitability. QSI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QSI had negative earnings in the past year.
QSI had a negative operating cash flow in the past year.
QSI had negative earnings in each of the past 5 years.
In the past 5 years QSI always reported negative operating cash flow.
QSI Yearly Net Income VS EBIT VS OCF VS FCFQSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -44.92%, QSI is not doing good in the industry: 81.03% of the companies in the same industry are doing better.
The Return On Equity of QSI (-49.69%) is worse than 67.24% of its industry peers.
Industry RankSector Rank
ROA -44.92%
ROE -49.69%
ROIC N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
QSI Yearly ROA, ROE, ROICQSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

QSI has a Gross Margin of 51.65%. This is comparable to the rest of the industry: QSI outperforms 58.62% of its industry peers.
The Profit Margin and Operating Margin are not available for QSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QSI Yearly Profit, Operating, Gross MarginsQSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

8

2. Health

2.1 Basic Checks

QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QSI has more shares outstanding
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QSI Yearly Shares OutstandingQSI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
QSI Yearly Total Debt VS Total AssetsQSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.68 indicates that QSI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.68, QSI is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
QSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.68
ROIC/WACCN/A
WACC10.36%
QSI Yearly LT Debt VS Equity VS FCFQSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

QSI has a Current Ratio of 10.75. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
QSI has a better Current ratio (10.75) than 93.10% of its industry peers.
A Quick Ratio of 10.59 indicates that QSI has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 10.59, QSI belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.75
Quick Ratio 10.59
QSI Yearly Current Assets VS Current LiabilitesQSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for QSI have decreased by -4.69% in the last year.
Looking at the last year, QSI shows a very strong growth in Revenue. The Revenue has grown by 40.20%.
EPS 1Y (TTM)-4.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.56%
Revenue 1Y (TTM)40.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-29.86%

3.2 Future

QSI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.46% yearly.
Based on estimates for the next years, QSI will show a very strong growth in Revenue. The Revenue will grow by 112.27% on average per year.
EPS Next Y21.76%
EPS Next 2Y12.26%
EPS Next 3Y11.56%
EPS Next 5Y10.46%
Revenue Next Year-5.95%
Revenue Next 2Y73.3%
Revenue Next 3Y129.76%
Revenue Next 5Y112.27%

3.3 Evolution

QSI Yearly Revenue VS EstimatesQSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
QSI Yearly EPS VS EstimatesQSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QSI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QSI Price Earnings VS Forward Price EarningsQSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QSI Per share dataQSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.26%
EPS Next 3Y11.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QSI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUM-SI INC

NASDAQ:QSI (11/10/2025, 2:59:01 PM)

1.655

+0.08 (+5.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-02 2026-03-02/amc
Inst Owners32.35%
Inst Owner Change-0.2%
Ins Owners5.03%
Ins Owner Change-0.37%
Market Cap335.14M
Revenue(TTM)3.18M
Net Income(TTM)-116.85M
Analysts77.14
Price Target2.72 (64.35%)
Short Float %12.54%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.15%
Min EPS beat(2)-23.16%
Max EPS beat(2)-13.15%
EPS beat(4)1
Avg EPS beat(4)-7.33%
Min EPS beat(4)-23.16%
Max EPS beat(4)28.97%
EPS beat(8)5
Avg EPS beat(8)4.82%
EPS beat(12)8
Avg EPS beat(12)4.46%
EPS beat(16)10
Avg EPS beat(16)-0.02%
Revenue beat(2)0
Avg Revenue beat(2)-29.58%
Min Revenue beat(2)-51.79%
Max Revenue beat(2)-7.37%
Revenue beat(4)0
Avg Revenue beat(4)-18.75%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)-3.79%
Revenue beat(8)2
Avg Revenue beat(8)-9.23%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.24%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-58.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-51.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 105.49
P/FCF N/A
P/OCF N/A
P/B 1.43
P/tB 1.43
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0.02
BVpS1.16
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -44.92%
ROE -49.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.65%
FCFM N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.84%
Cap/Sales 124.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.75
Quick Ratio 10.59
Altman-Z 3.68
F-Score4
WACC10.36%
ROIC/WACCN/A
Cap/Depr(3y)214.69%
Cap/Depr(5y)249.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.56%
EPS Next Y21.76%
EPS Next 2Y12.26%
EPS Next 3Y11.56%
EPS Next 5Y10.46%
Revenue 1Y (TTM)40.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-29.86%
Revenue Next Year-5.95%
Revenue Next 2Y73.3%
Revenue Next 3Y129.76%
Revenue Next 5Y112.27%
EBIT growth 1Y0.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.36%
EBIT Next 3Y4.62%
EBIT Next 5Y5.42%
FCF growth 1Y-3.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.28%
OCF growth 3YN/A
OCF growth 5YN/A

QUANTUM-SI INC / QSI FAQ

What is the ChartMill fundamental rating of QUANTUM-SI INC (QSI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to QSI.


Can you provide the valuation status for QUANTUM-SI INC?

ChartMill assigns a valuation rating of 0 / 10 to QUANTUM-SI INC (QSI). This can be considered as Overvalued.


How profitable is QUANTUM-SI INC (QSI) stock?

QUANTUM-SI INC (QSI) has a profitability rating of 0 / 10.